​
​

Carmell Therapeutics (ALPA) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Carmell Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$12.32K

Carmell Therapeutics Revenue by Period

Carmell Therapeutics Revenue by Year

DateRevenueChange
2022-12-31-100.00%
2021-12-31--

Carmell Therapeutics generated - in revenue during NA 2022, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Carmell Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$12.32K100.00%
2024-03-31--100.00%
2023-12-31$-3.73M-200.00%
2023-09-30$3.73M100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30--

Carmell Therapeutics generated $12.32K in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Carmell Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ANZUEnvoy Medical$316.00K$68.00K
AMAORoyalty Management$22.73K$38.33K
FACTComplete Solaria-$24.59M
BYTSAirship AI--
ALPACarmell Therapeutics-$12.32K
ADER26 Capital Acquisition--

ALPA Revenue FAQ

What is Carmell Therapeutics’s yearly revenue?

Carmell Therapeutics's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. The company's yearly revenue for 2021 was $0, representing an increase of 0% compared to 2020.

What is Carmell Therapeutics’s quarterly revenue?

Carmell Therapeutics's quarterly revenue for Q2 2024 was $12.32K, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). ALPA's quarterly revenue for Q4 2023 was $-3.729M, a -200.00% decrease from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).